GDES2026 is the premier international virtual conference for leading endocrinologists, diabetologists, and metabolic researchers from around the globe. Taking place on July 02-03, 2026, this congress is a vital platform for the dissemination of cutting-edge endocrine research and diabetes treatment strategies.
The Milner Institute's annual showcase highlights promising Pre-Series A companies from our bio-incubator, local accelerators, as well as other selected national and international companies.
Bringing together 25+ speakers and 60+ senior attendees from AstraZeneca, Genmab, Immunocore, Merus, Sanofi, Roche, and more the inaugural World Bispecific Summit Europe it’s set to be a key meeting point for teams driving discovery, engineering, CMC, safety, and clinical development of bispecifics.
The Milner Therapeutics Symposium is an annual flagship event in Cambridge, bringing together 750 leading scientists, innovators and investors from academia and industry.
Transitioning from preclinical development into first-in-human studies is one of the most critical and complex stages in drug development. Early strategic decisions can significantly influence timelines, regulatory interactions, study success and overall programme progression.
Join our live Q&A webinar to put your questions to experts who have seen and done it all, and gain practical insight into navigating the path from preclinical promise to clinical reality.
Bionow's Neuroscience Conference brings together academics, clinicians and industry leaders to explore breakthroughs in the discovery, development and delivery of treatments for neurological diseases.
Innovate UK is hosting a full day Link & Learn event showcasing the Sustainable Medicines Manufacturing Innovation Programme (SMMIP) and the real-world impact its funded projects are set to deliver.
The event will bring together organisations across the medicines manufacturing sector to explore sustainable innovations and future adoption. The programme includes opportunities to link & learn directly with SMMIP projects, explore critical enablers for success and an evening networking session sponsored by ABPI.
ON Helix offers a high content mix of plenary talks and panels from key opinion leaders, Exhibition area, assembling an array of exhibitors; all great examples of helping to enable the translation of ideas into better patient outcomes.
Co-organisers, Professor Fiona Ducotterd, Alzheimer’s Research UK UCL Drug Discovery Institute, and Doctor Jim Ray, Belfer Neurodegeneration Consortium, MD Anderson Neuroscience Drug Discovery Institute, have curated this one-day Industry Masterclass in Drug Discovery and Development, hosted by Professor Mike Hanna, Director of Queen Square Institute of Neurology and Professor Sarah Tabrizi, Head of UCL Huntington’s Disease Research Centre, this day brings together stakeholders across sectors to share insights about the roles and disciplines that come together to make new medicines.
